| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.14▲ | 0.15▼ | 0.15▼ | 0.16▼ | 0.29▼ |
| MA10 | 0.15▼ | 0.15▼ | 0.15▼ | 0.19▼ | 0.61▼ |
| MA20 | 0.15▼ | 0.15▼ | 0.15▼ | 0.39▼ | 0.83▼ |
| MA50 | 0.15▼ | 0.17▼ | 0.18▼ | 0.75▼ | 1.01▼ |
| MA100 | 0.15▼ | 0.19▼ | 0.30▼ | 0.88▼ | 1.19▼ |
| MA200 | 0.17▼ | 0.36▼ | 0.63▼ | 0.96▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | 0.000▲ | 0.001▲ | -0.005▼ | -0.092▼ |
| RSI | 38.853▼ | 35.865▼ | 29.889▼ | 14.593▼ | 21.941▼ |
| STOCH | 7.935▼ | 11.370▼ | 37.177 | 3.562▼ | 4.469▼ |
| WILL %R | -83.803▼ | -86.310▼ | -81.921▼ | -99.350▼ | -99.701▼ |
| CCI | -76.814 | -144.651▼ | -174.216▼ | -80.926 | -133.952▼ |
|
Monday, December 01, 2025 06:05 AM
These achievements include positive top-line results from the first cohort, unanimous approval from the independent Data and Safety Monitoring Board (DSMB) to continue Phase I/IIa clinical trial and ...
|
|
Saturday, November 29, 2025 09:25 PM
Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel neuroplastogen-derived therapeutics ...
|
|
Wednesday, November 26, 2025 12:32 AM
Clearmind Medicine rose 7.09% in pre-market trading after announcing enrollment of first patient in trial for alcohol use disorder.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/12/25 | 0.1558 | 0.1558 | 0.1416 | 0.1439 | 3,742,167 |
| 28/11/25 | 0.1585 | 0.1585 | 0.1478 | 0.1546 | 4,138,033 |
| 26/11/25 | 0.156 | 0.16 | 0.1404 | 0.1551 | 18,051,583 |
| 25/11/25 | 0.1928 | 0.1937 | 0.152 | 0.16 | 57,038,528 |
| 24/11/25 | 0.1941 | 0.2025 | 0.1867 | 0.1985 | 5,646,795 |
| 21/11/25 | 0.2108 | 0.217 | 0.1735 | 0.1831 | 4,396,015 |
| 20/11/25 | 0.2008 | 0.2244 | 0.1946 | 0.1988 | 7,520,975 |
| 19/11/25 | 0.21 | 0.21 | 0.18 | 0.2025 | 11,758,825 |
| 18/11/25 | 0.3521 | 0.3975 | 0.20 | 0.2164 | 87,002,723 |
| 17/11/25 | 0.26 | 0.2949 | 0.25 | 0.2769 | 13,151,056 |
|
|
||||
|
|
||||
|
|